A Randomized Phase 3 Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High Risk Retroperitoneal Sarcoma
Age: 18+
Phase: 3
Locations:
- Birmingham – University Hospitals Birmingham – Queen Elizabeth Medical Centre
- Glasgow – NHS Greater Glasgow and Clyde – Beatson West of Scotland Cancer Centre – Gartnavel General Hospital
- Leeds – Leeds Teaching Hospitals NHS Trust, St James’ University Hospital
- Liverpool – Clatterbridge Cancer Centre
- London – The Royal Marsden Hospital
- Nottingham – Nottingham University Hospitals NHS Trust, City Hospital
- Oxford – Oxford University Hospitals NHS Trust, Churchill Hospital
- Wirral – Clatterbridge Cancer Centre
This study will assess the potential benefits of chemotherapy before surgery to improve disease control and survival in patients with high-risk retroperitoneal sarcoma.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
